Tags : Revcovi


Leadiant Biosciences Revcovi’s (elapegademase-lvlr) Receives FDA Approval for Adenosine Deaminase

Shots: The approval is based on two study results assessing Revcovi in patients and demonstrated in an increase in ADA activity, reduction in concentration of toxic metabolites with an improvement in total lymphocyte counts Leadiant Biosciences’ Revcovi has received FDA’s Fast Track, Priority Review & ODD designation on 7 Jun, 2017, 27 Jun, 2018 & […]Read More